Detalhe da pesquisa
1.
Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design.
Oncologist
; 26(3): e394-e402, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33219618
2.
A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience.
Oncologist
; 26(5): e769-e779, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33687747
3.
QualFatigue study: which factors influence the use of specific interventions for breast cancer survivors with fatigue? A cross-sectional exploratory study.
Support Care Cancer
; 29(8): 4827-4834, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33547524
4.
A qualitative evaluation of the use of interventions to treat fatigue among cancer survivors: A healthcare provider's view.
Eur J Cancer Care (Engl)
; 30(2): e13370, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33191520
5.
Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers.
Oncologist
; 25(10): e1509-e1515, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32735386
6.
Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma.
Cancer Drug Resist
; 6(3): 517-546, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37842234
7.
Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma.
Cancers (Basel)
; 15(4)2023 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831409
8.
Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter-Society Consensus II D femoropopliteal lesions.
J Vasc Surg
; 56(6): 1598-605, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23044257
9.
Biomarker-driven immunotherapy for precision medicine in prostate cancer.
Per Med
; 19(1): 51-66, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34873959
10.
Impact of abiraterone acetate plus prednisone in patients with castration-sensitive prostate cancer and visceral metastases over four years of follow-up: A post-hoc exploratory analysis of the LATITUDE study.
Eur J Cancer
; 162: 56-64, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34953443
11.
PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate Cancer.
Drugs
; 82(7): 719-733, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35511402
12.
Patient Preference Between Cabazitaxel and Docetaxel for First-line Chemotherapy in Metastatic Castration-resistant Prostate Cancer: The CABADOC Trial.
Eur Urol
; 81(3): 234-240, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34789394
13.
Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy.
Int J Radiat Oncol Biol Phys
; 113(4): 825-832, 2022 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35461737
14.
Should androgen deprivation therapy and other systemic treatments be used in men with prostate cancer and a rising PSA post-local treatments?
Ther Adv Med Oncol
; 13: 17588359211051870, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34707693
15.
Redefining cancer of unknown primary: Is precision medicine really shifting the paradigm?
Cancer Treat Rev
; 97: 102204, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33866225
16.
Cabazitaxel activity in men with metastatic castration-resistant prostate cancer with and without DNA damage repair defects.
Eur J Cancer
; 159: 87-97, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34742160
17.
Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers.
Cell Death Dis
; 12(3): 258, 2021 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33707411
18.
New rising entities in cancer of unknown primary: Is there a real therapeutic benefit?
Crit Rev Oncol Hematol
; 147: 102882, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32106012
19.
Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancer.
Ther Adv Med Oncol
; 12: 1758835920978134, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33488778
20.
Long-term Castration-related Outcomes in Patients With High-risk Localized Prostate Cancer Treated With Androgen Deprivation Therapy With or Without Docetaxel and Estramustine in the UNICANCER GETUG-12 Trial.
Clin Genitourin Cancer
; 18(6): 444-451, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32349927